ArticleBMC pediatrics2025
Efficacy of repetitive peripheral magnetic stimulation in managing spasticity of the triceps surae muscle in children with cerebral palsy: a retrospective analysis of influencing factors.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCerebral palsy (CP) is a neurodevelopmental disorder characterized by spasticity, which significantly impairs motor function. Traditional treatments offer limited relief and carry risks. Repetitive peripheral magnetic stimulation (rPMS) presents a promising non-invasive alternative. This study aimed to evaluate the efficacy of rPMS in managing triceps surae spasticity in children with CP and to identify factors influencing its effectiveness.
methodsA retrospective cohort study was conducted with 271 children aged 6-12 years with CP (GMFCS levels I-II). Participants were assigned to conventional treatment (n = 131) or rPMS (n = 140) groups. Outcomes were assessed using the Modified Tardieu Scale (MTS), Berg balance scale (BSS), Edinburgh Visual Gait Score (EVGS) and integrated electromyography (IEMG). Treatment efficacy was defined based on improvements in the Gross Motor Function Measure-88 (GMFM-88). Logistic regression identified factors influencing rPMS efficacy.
resultsThe rPMS group showed significantly greater improvements in spasticity (reduced MTS and EVGS scores), balance (increased BBS scores), and muscle coordination (IEMG changes) compared to the conventional group (P < 0.05). The overall effectiveness rate was 85.00% for rPMS vs. 74.81% for conventional treatment (P = 0.036). Multivariate analysis identified the type of CP (diplegia vs. hemiplegia) and patient compliance as significant factors influencing the efficacy of rPMS.
conclusionOur results indicate that rPMS significantly controls spasticity and improves lower limb motor function. Importantly, we identified that certain types of CP and patient compliance are significant predictors of treatment efficacy. These findings suggest that optimizing rPMS protocols based on patient-specific characteristics can enhance therapeutic outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.